CVA Family Office, LLC - MOLECULIN BIOTECH INC ownership

MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D200. A total of 28 filers reported holding MOLECULIN BIOTECH INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CVA Family Office, LLC ownership history of MOLECULIN BIOTECH INC
ValueSharesWeighting
Q2 2023$289
-39.8%
5000.0%0.00%
Q1 2023$480
-9.4%
5000.0%0.00%
Q4 2022$530
-47.0%
5000.0%0.00%
Q3 2022$1,0000.0%5000.0%0.00%
Q2 2022$1,0000.0%5000.0%0.00%
Q1 2022$1,0000.0%5000.0%0.00%
Q4 2021$1,000
-50.0%
5000.0%0.00%
-100.0%
Q2 2021$2,0000.0%5000.0%0.00%0.0%
Q1 2021$2,0005000.00%
Other shareholders
MOLECULIN BIOTECH INC shareholders Q3 2022
NameSharesValueWeighting ↓
Sio Capital Management, LLC 963,000$3,929,0000.80%
OCCUDO QUANTITATIVE STRATEGIES LP 22,158$90,0000.02%
TWO SIGMA SECURITIES, LLC 27,224$111,0000.01%
Harel Insurance Investments & Financial Services Ltd. 10,000$136,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 31,500$129,0000.00%
Cubist Systematic Strategies, LLC 26,624$109,0000.00%
CVA Family Office, LLC 500$2,0000.00%
Squarepoint Ops LLC 28,904$118,0000.00%
RAYMOND JAMES & ASSOCIATES 14,986$61,0000.00%
OSAIC HOLDINGS, INC. 801$3,0000.00%
View complete list of MOLECULIN BIOTECH INC shareholders